Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Glucocorticoid Inflammation Paradox in Human Skeletal Muscle

Authors not listed

Texas A&M University · 2019

Abstract

In this project, we propose to investigate the metabolic consequences of glucocorticoid therapy, given orally as a 6 day Medrol Dose pack, on human skeletal muscle as measured by western blotting and PCR and skeletal muscle mitochondrial capacity as measured by High-Resolution Respirometry in healthy individuals. Medrol is an FDA approved drug with many clinical indications.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-14 MST

Cite this

APA
Anonymous. (2019). Glucocorticoid Inflammation Paradox in Human Skeletal Muscle. <em>Texas A&M University</em>. https://clinicaltrials.gov/study/NCT03529929
Vancouver
Anonymous. Glucocorticoid Inflammation Paradox in Human Skeletal Muscle. Texas A&M University. 2019.
BibTeX
@misc{anon2019Glucoc, title = {Glucocorticoid Inflammation Paradox in Human Skeletal Muscle}, author = {Anonymous}, journal = {Texas A&M University}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings